A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis

Clinical Rheumatology

Volumn 35, Issue 4, 2016, Pages 953-960

  Shah, Shivani ^a,d   Havill, John ^b   Hafizur Rahman, M ^c   Geetha, Duvuru ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b Kidney Specialists of Southern Nevada   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

ANCA negative; GPA; MPA; Vasculitis

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOGLOBULIN; MYCOPHENOLATE MOFETIL; NEUTROPHIL CYTOPLASMIC ANTIBODY; RITUXIMAB; STEROID; CREATININE;

ADULT; AMERICAN; ANCA ASSOCIATED VASCULITIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX NEPHRITIS; KIDNEY BIOPSY; KIDNEY FUNCTION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATHOGENESIS; PAUCI IMMUNE GLOMERULONEPHRITIS; PRIORITY JOURNAL; REMISSION; REVIEW; TREATMENT OUTCOME; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; BIOPSY; BLOOD; FIBROSIS; GLOMERULONEPHRITIS; IMMUNOLOGY; KIDNEY; KIDNEY FUNCTION TEST; PATHOLOGY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX; TIME FACTOR; UNITED STATES; VASCULITIS;

ADULT; AGED; ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; BIOPSY; CREATININE; FEMALE; FIBROSIS; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VASCULITIS;

EID: 84944582114     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-015-3086-8     Document Type: Review

References (23)

1. Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318(25):1651–1657
2. Booth AD, Almond MK, Burns A et al (2003) Outcome of ANC Aassociated renal vasculitis: a 5-year retrospective study. Am J Kidney Dis 41(4):776–784
3. Jennette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 337(21):1512–1523
4. Jennette JC, Falk RJ, Gasim AH (2011) Pathogenesis of antineutrophil cytoplasmic autoantibody vasculitis. Curr Opin Nephrol Hypertens 20(3):263–270
5. Hedger N, Stevens J, Drey N, Walker S, Roderick P (2000) Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in wessex, UK: a 10-year retrospective study. Nephrol Dial Transplant 15(10):1593–1599
6. Chen M, Yu F, Wang SX, Zou WZ, Zhao MH, Wang HY (2007) Antineutrophil cytoplasmic autoantibody-negative pauci-immune crescentic glomerulonephritis. J Am Soc Nephrol 18(2):599–605
7. Hung PH, Chiu YL, Lin WC et al (2006) Poor renal outcome of antineutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis in Taiwanese. J Formos Med Assoc 105(10):804–812
8. Eisenberger U, Fakhouri F, Vanhille P et al (2005) ANCA-negative pauci-immune renal vasculitis: histology and outcome. Nephrol Dial Transplant 20(7):1392–1399
9. Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. proposal of an international consensus conference. Arthritis Rheum 37(2):187–192
10. Stone JH, Hoffman GS, Merkel PA et al (2001) A disease-specific activity index for Wegener’s granulomatosis: modification of the birmingham vasculitis activity score. International Network for the Study of the Systemic Vasculitides (INSSYS). Arthritis Rheum 44(4):912–920
11. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150(9):604–612
12. Bajema IM, Hagen EC, Hermans J et al (1999) Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis. Kidney Int 56(5):1751–1758
13. Hauer HA, Bajema IM, Van Houwelingen HC et al (2002) Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients. Kidney Int 62(5):1732–1742
14. de Lind vanWijngaarden RA, Hauer HA, Wolterbeek R et al (2006) Clinical and histologic determinants of renal outcome in ANCAassociated vasculitis: a prospective analysis of 100 patients with severe renal involvement. J Am Soc Nephrol 17(8):2264–2274
15. Day CJ, Howie AJ, Nightingale P et al (2010) Prediction of ESRD in pauci-immune necrotizing glomerulonephritis: quantitative histomorphometric assessment and serum creatinine. Am J Kidney Dis 55(2):250–258
16. Carvalho D, Savage CO, Isenberg D, Pearson JD (1999) IgG antiendothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 42(4):631–640
17. Guilpain P, Mouthon L (2008) Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases. Clin Rev Allergy Immunol 35(1–2):59–65
18. Sebastian JK, Mahr AD, Ahmed SS et al (2007) Antiendothelial cell antibodies in patients with Wegener’s granulomatosis: prevalence and correlation with disease activity and manifestations. J Rheumatol 34(5):1027–1031
19. Gobel U, Eichhorn J, Kettritz R et al (1996) Disease activity and autoantibodies to endothelial cells in patients withWegener’s granulomatosis. Am J Kidney Dis 28(2):186–194
20. Kain R, Exner M, Brandes R et al (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 14(10):1088–1096
21. Roth AJ, Brown MC, Smith RN et al (2012) Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis. J Am Soc Nephrol 23(3):545–555
22. Kain R, Tadema H, McKinney EF et al (2012) High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis. J Am Soc Nephrol 23(3):556–566
23. Roth AJ, Ooi JD, Hess JJ et al (2013) Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest 123(4):1773–1783